Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H9BrO2 |
| Molecular Weight | 301.135 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
BrC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O
InChI
InChIKey=NPUZIGSOEWMFKK-UHFFFAOYSA-N
InChI=1S/C15H9BrO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. | 2013-09-05 |
|
| Further studies of bromindione, a newer anticoagulant. | 1967-07 |
|
| Study of bromindione, a new anticoagulant. | 1962-01-13 |
|
| p-Bromindione: a new, potent, long-acting oral anticoagulant drug. | 1961-09-09 |
|
| [Anticoagulant effect of 2-(4-bromo) phenyl-1, 3-indandione (fluidemin)]. | 1956-10-15 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13749480
The dose range used for oral Bromindione is between 5 mg to 40 mg, with the most common dosing regime of 10 or 15 mg.
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1146-98-1
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
C174809
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
14369
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL288496
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
m2670
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
1242
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
OQZ7BND2QN
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
100000088694
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
SUB05915MIG
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
3037
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
759118
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
DTXSID8046244
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY | |||
|
C010689
Created by
admin on Mon Mar 31 17:45:57 GMT 2025 , Edited by admin on Mon Mar 31 17:45:57 GMT 2025
|
PRIMARY |
ACTIVE MOIETY